Post

The experimental mRNA cancer vaccine, combined with the approved drug Keytruda, reduced the risk that patients’ cancer came back after surgery or that they died by 42% compared with Keytruda alone, opening up a path for an entirely new way to treat melanoma. https://cnn.it/3VOqr1r